Guru Fundamental Report for UNH

Validea's guru fundamental report indicates UnitedHealth Group (UNH) scores 69% using the Martin Zweig Growth Investor model, which prioritizes accelerating earnings and sales growth, reasonable valuations, and low debt. While UNH ranks highest among 22 strategies for this model, its 69% rating falls below the 80% threshold typically signaling strategy interest. This is primarily due to the stock failing criteria for sales growth rate, earnings persistence, and long-term EPS growth, despite passing on metrics like P/E ratio and current quarter earnings.

Analysis

UnitedHealth Group (UNH) garners a score of 69% on Validea's Martin Zweig-based Growth Investor model, a rating that is noted as the highest among 22 strategies but falls short of the 80% threshold that typically indicates model interest. The analysis reveals a dichotomy in the company's fundamentals. On one hand, UNH exhibits strong current-quarter performance, passing criteria for earnings growth, which is shown to be accelerating relative to the prior three quarters and its historical rate. It also screens positively on its P/E ratio and insider transaction activity. On the other hand, the model flags significant weaknesses for a growth-focused strategy, as UNH fails on its sales growth rate, earnings persistence, long-term EPS growth, and earnings growth over the past several quarters. This suggests that while recent bottom-line momentum and valuation are favorable, the company lacks the consistent, accelerating top-line growth and long-term earnings track record that the Zweig strategy prioritizes.

Key Decisions for Investors

• Given the failure on key metrics such as sales growth rate and earnings persistence, investors should treat the strong current-quarter EPS growth with caution, as its sustainability may be in question.
• The stock's profile may appeal to investors focused on reasonable valuation and short-term earnings momentum, but for those strictly following a growth-at-a-reasonable-price (GARP) strategy like Zweig's, the lack of consistent top-line growth and long-term earnings power are significant red flags.
• Monitor future earnings reports closely for an improvement in the sales growth rate, as a continued divergence between strong EPS growth and weak revenue growth could indicate reliance on margin improvement or non-recurring items rather than fundamental business expansion.